UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 65

Sortiert nach

Efficacy and Safety of Trastuzumab as a Single Agent in First-Line Treatment of HER2 -Overexpressing Metastatic Breast Cancer

Journal of clinical oncology, 2023-03, Vol.41 (9), p.1638-1645

2023

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer

Journal of clinical oncology, 2002-02, Vol.20 (3), p.719-726

2002

Link zum Volltext

Verfügbarkeit prüfen

Reduced Cardiotoxicity and Preserved Antitumor Efficacy of Liposome-Encapsulated Doxorubicin and Cyclophosphamide Compared With Conventional Doxorubicin and Cyclophosphamide in a Randomized, Multicenter Trial of Metastatic Breast Cancer

Journal of clinical oncology, 2001-03, Vol.19 (5), p.1444-1454

2001

Link zum Volltext

Verfügbarkeit prüfen

Palifermin Reduces the Incidence of Oral Mucositis in Patients With Metastatic Colorectal Cancer Treated With Fluorouracil-Based Chemotherapy

Journal of clinical oncology, 2006-11, Vol.24 (33), p.5194-5200

2006

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and Safety of Trastuzumab as a Single Agent in First-Line Treatment of HER2-Overexpressing Metastatic Breast Cancer

Journal of clinical oncology, 2002-02, Vol.20 (3), p.719-726

Vogel, C. L.

2002

Link zum Volltext

Verfügbarkeit prüfen

Phase I/II Trial of IDEC-Y2B8 Radioimmunotherapy for Treatment of Relapsed or Refractory CD20+ B-Cell Non-Hodgkin's Lymphoma

Journal of clinical oncology, 1999-12, Vol.17 (12), p.3793-3803

1999

Link zum Volltext

Verfügbarkeit prüfen

Abstract CT026: Phase I trial of HuMab-5B1 (MVT-5873), a novel monoclonal antibody targeting sLea, in patients with advanced pancreatic cancer and other CA19-9 positive malignancies

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.CT026-CT026

2016

Link zum Volltext

Verfügbarkeit prüfen

Phase II Study of Direct Intralesional Gene Transfer of Allovectin-7, an HLA-B7/β2-Microglobulin DNA-Liposome Complex, in Patients with Metastatic Melanoma

Clinical cancer research, 2001-08, Vol.7 (8), p.2285-2291

2001

Link zum Volltext

Verfügbarkeit prüfen

Randomized Phase I Trial of Recombinant Human Keratinocyte Growth Factor Plus Chemotherapy: Potential Role as Mucosal Protectant

Journal of clinical oncology, 2003-04, Vol.21 (8), p.1452-1458

2003

Link zum Volltext

Verfügbarkeit prüfen

First-Line Herceptin® Monotherapy in Metastatic Breast Cancer

Oncology, 2001-01, Vol.61 (2), p.37-42

2001

Link zum Volltext

Verfügbarkeit prüfen

Randomized Trial of a Slow-Release Versus a Standard Formulation of Cytarabine for the Intrathecal Treatment of Lymphomatous Meningitis

Journal of clinical oncology, 1999-10, Vol.17 (10), p.3110-3116

1999

Link zum Volltext

Verfügbarkeit prüfen

PR-104 plus sorafenib in patients with advanced hepatocellular carcinoma

Cancer chemotherapy and pharmacology, 2011-08, Vol.68 (2), p.539-545

2011

Link zum Volltext

Verfügbarkeit prüfen

An open label, single-arm, phase II multicenter study of the safety and efficacy of CG0070 oncolytic vector regimen in patients with BCG-unresponsive non–muscle-invasive bladder cancer: Interim results

Urologic oncology, 2018-10, Vol.36 (10), p.440-447

2018

Link zum Volltext

Verfügbarkeit prüfen

An open label trial of sustained-release cytarabine (DepoCyt) for the intrathecal treatment of solid tumor neoplastic meningitis

Journal of neuro-oncology, 2002-05, Vol.57 (3), p.231-239

2002

Link zum Volltext

Verfügbarkeit prüfen

CVM-1118: A potent oral anti-vasculogenic mimicry (VM) agent in patients with advanced neuroendocrine tumors (NETs)—A phase IIa study

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e16235-e16235

2023

Link zum Volltext

Verfügbarkeit prüfen

MP43-02 CG0070, AN ONCOLYTIC ADENOVIRUS, FOR BCG-UNRESPONSIVE NON-MUSCLE-INVASIVE BLADDER CANCER (NMIBC): 18 MONTH FOLLOW-UP FROM A MULTICENTER PHASE II TRIAL

The Journal of urology, 2019-04, Vol.201 (Supplement 4)

2019

Link zum Volltext

Verfügbarkeit prüfen

LBA24 CG0070, AN ONCOLYTIC ADENOVIRUS, FOR BCG-UNRESPONSIVE NON-MUSCLE-INVASIVE BLADDER CANCER (NMIBC): 12 MONTH INTERIM RESULTS FROM A MULTICENTER PHASE II TRIAL

The Journal of urology, 2018-04, Vol.199 (4), p.e1166-e1166

2018

Link zum Volltext

Verfügbarkeit prüfen

Phase II Trial of Weekly Paclitaxel in Patients With Previously Treated Advanced Urothelial Cancer

Journal of clinical oncology, 2002-02, Vol.20 (4), p.937-940

Vaughn, D. J.

2002

Link zum Volltext

Verfügbarkeit prüfen

Phase I dose escalation study of CVM-1118, a novel anti-vascular mimicry agent, in patients with advanced cancers

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.2580-2580

2017

Link zum Volltext

Verfügbarkeit prüfen

Abstract CT140: Phase I dose escalation study of 177Lu-HuMab-5B1 (MVT-1075) in combination with MVT-5873 as radioimmunotherapy (RIT) in subjects with relapsed / refractory pancreatic cancer or other CA19-9+ malignancies

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.CT140-CT140

2018

Link zum Volltext

Verfügbarkeit prüfen

HuMab-5B1 (MVT-5873), a mAb targeting sLe a , in combination with first-line gemcitabine plus nab-paclitaxel (gem/nab-P) for patients with pancreatic cancer (PDAC) and other CA19-9 positive malignancies

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.e16235-e16235

2018

Link zum Volltext

Verfügbarkeit prüfen

A phase Ib/II study of oral nanatinostat (N) and valganciclovir (VG) in subjects with Epstein-Barr virus (EBV)-associated lymphomas

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.7551-7551

2019

Link zum Volltext

Verfügbarkeit prüfen

phase I trial of PR-104, a nitrogen mustard prodrug activated by both hypoxia and aldo-keto reductase 1C3, in patients with solid tumors

Cancer chemotherapy and pharmacology, 2010-03, Vol.65 (4), p.791-801

2010

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 65

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(60)
Mit Volltextzugriff
(57)

Publikationsform

Sprache

Englisch
(65)
Japanisch
(7)

Erscheinungsjahr

n.n

Thema

Humans
(34)
Life Sciences & Biomedicine
(31)
Science & Technology
(31)
Oncology
(21)
Female
(20)
Biological And Medical Sciences
(18)
Medical Sciences
(17)
Middle Aged
(17)
Adult
(16)
Male
(15)
Aged
(14)
Pharmacology. Drug Treatments
(14)
Antineoplastic Agents
(13)
Treatment Outcome
(9)
Antibodies, Monoclonal - Therapeutic Use
(8)
Antineoplastic Agents - Therapeutic Use
(8)
Chemotherapy
(7)
Aged, 80 And Over
(6)
Breast Neoplasms - Drug Therapy
(6)
Cancer Research
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Phase I/II study of the hypoxia-activated prodrug PR104 in refractory/relapsed acute myeloid leukemia and acute lymphoblastic leukemia

Efficacy and Safety of Trastuzumab as a Single Agent in First-Line Treatment of HER2 -Overexpressing Metastatic Breast Cancer

Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer

Reduced Cardiotoxicity and Preserved Antitumor Efficacy of Liposome-Encapsulated Doxorubicin and Cyclophosphamide Compared With Conventional Doxorubicin and Cyclophosphamide in a Randomized, Multicenter Trial of Metastatic Breast Cancer

Palifermin Reduces the Incidence of Oral Mucositis in Patients With Metastatic Colorectal Cancer Treated With Fluorouracil-Based Chemotherapy

Efficacy and Safety of Trastuzumab as a Single Agent in First-Line Treatment of HER2-Overexpressing Metastatic Breast Cancer

Phase I/II Trial of IDEC-Y2B8 Radioimmunotherapy for Treatment of Relapsed or Refractory CD20+ B-Cell Non-Hodgkin's Lymphoma

Abstract CT026: Phase I trial of HuMab-5B1 (MVT-5873), a novel monoclonal antibody targeting sLea, in patients with advanced pancreatic cancer and other CA19-9 positive malignancies

Phase II Study of Direct Intralesional Gene Transfer of Allovectin-7, an HLA-B7/β2-Microglobulin DNA-Liposome Complex, in Patients with Metastatic Melanoma

Randomized Phase I Trial of Recombinant Human Keratinocyte Growth Factor Plus Chemotherapy: Potential Role as Mucosal Protectant

First-Line Herceptin® Monotherapy in Metastatic Breast Cancer

Randomized Trial of a Slow-Release Versus a Standard Formulation of Cytarabine for the Intrathecal Treatment of Lymphomatous Meningitis

PR-104 plus sorafenib in patients with advanced hepatocellular carcinoma

An open label, single-arm, phase II multicenter study of the safety and efficacy of CG0070 oncolytic vector regimen in patients with BCG-unresponsive non–muscle-invasive bladder cancer: Interim results

An open label trial of sustained-release cytarabine (DepoCyt) for the intrathecal treatment of solid tumor neoplastic meningitis

CVM-1118: A potent oral anti-vasculogenic mimicry (VM) agent in patients with advanced neuroendocrine tumors (NETs)—A phase IIa study

MP43-02 CG0070, AN ONCOLYTIC ADENOVIRUS, FOR BCG-UNRESPONSIVE NON-MUSCLE-INVASIVE BLADDER CANCER (NMIBC): 18 MONTH FOLLOW-UP FROM A MULTICENTER PHASE II TRIAL

LBA24 CG0070, AN ONCOLYTIC ADENOVIRUS, FOR BCG-UNRESPONSIVE NON-MUSCLE-INVASIVE BLADDER CANCER (NMIBC): 12 MONTH INTERIM RESULTS FROM A MULTICENTER PHASE II TRIAL

Phase II Trial of Weekly Paclitaxel in Patients With Previously Treated Advanced Urothelial Cancer

Phase I dose escalation study of CVM-1118, a novel anti-vascular mimicry agent, in patients with advanced cancers

Abstract CT140: Phase I dose escalation study of 177Lu-HuMab-5B1 (MVT-1075) in combination with MVT-5873 as radioimmunotherapy (RIT) in subjects with relapsed / refractory pancreatic cancer or other CA19-9+ malignancies

HuMab-5B1 (MVT-5873), a mAb targeting sLe a , in combination with first-line gemcitabine plus nab-paclitaxel (gem/nab-P) for patients with pancreatic cancer (PDAC) and other CA19-9 positive malignancies

A phase Ib/II study of oral nanatinostat (N) and valganciclovir (VG) in subjects with Epstein-Barr virus (EBV)-associated lymphomas

phase I trial of PR-104, a nitrogen mustard prodrug activated by both hypoxia and aldo-keto reductase 1C3, in patients with solid tumors

Suchergebnisse filtern